Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2021, vol. 30, nr 12, December, p. 1221–1223

doi: 10.17219/acem/144440

Publication type: editorial

Language: English

License: Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Cite as:


Sharman JE, Kosmala W. High-quality medical research requires that equipment has been validated for accuracy. Adv Clin Exp Med. 2021;30(12):1221–1223. doi:10.17219/acem/144440

High-quality medical research requires that equipment has been validated for accuracy

James E. Sharman1,D, Wojciech Kosmala2,E

1 Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia

2 Department of Cardiovascular Imaging, Institute of Heart Diseases, Wroclaw Medical University, Poland

Abstract

It is not always appreciated that medical equipment may be cleared by regulatory authorities to sell within a country, without ever having been tested for accuracy performance according to scientific validation standards. Instead, manufacturers can undertake in-house accuracy testing, using variable methods and without any requirement for test results to be made publicly available. This lack of full transparency together with potential for industry bias can place doubt over the quality of validation results provided to regulatory authorities. Currently, this situation affects the field of hypertension research, where most blood pressure devices have not been independently validated for accuracy according to international scientific standards, nor as expected in clinical practice guidelines. More attention should be paid to such practices in order to improve the quality of research and to optimize further translation of scientific findings to clinical practice. The clinical implications of inaccurate measurements in research can be far-reaching, ultimately impacting on a patient’s health. Well-planned validating studies should be more widely considered for new devices that are candidates to be used in research protocols. The awareness of the lack or uncertain validation of equipment used for verifying research hypotheses should prompt all investigators to revisit the idea of conducting the study or, at least, to acknowledge this issue as a relevant study limitation. One of the ways in which authors submitting research findings for publication can add to the quality of the reporting of their work is to ensure reference to the accuracy validation of their research equipment.

Key words: medical devices, equipment and supplies, standards, performance

The international community and funders of research expect the study to be conducted ethically and with high quality, such that it is rigorous, transparent, reproducible, and avoids waste.1 These expectations are not only essential for the translation of research knowledge to the benefit of the wider community, but also help to promote trust in research findings and deliver the highest value for the money that is invested in research.2 The failure of many research discoveries to be reproduced by independent investigators is a symptom of rigorous research methods not always being applied, and indicates that more training to improve the understanding of high-quality research methods, particularly for research apprentices, is needed.1, 3

Resources to aid the rigor and accountability of research practice, from the design to conduct and reporting of research outcomes, have been developed for researchers (e.g., Enhancing the QUAlity and Transparency Of health Research (EQUATOR) network, Cochrane Collaboration).4, 5 Working towards similar intent to improve the quality of research publications, the International Committee of Medical Journal Editors (ICMJE) publishes “Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals”.6 These recommendations align with best practice standards to assist all those involved in publishing medical research to present unbiased findings clearly and accurately. The journal “Advances in Clinical and Experimental Medicine” is an ICMJE member journal that requires authors of all submitted papers to adhere to the ICMJE recommendations.

The ICMJE Recommendations rightly state that, in order to allow others to reproduce the results of research, there should be sufficient detail provided on the methods, equipment and procedures of the research.6 However, a factor that is not considered within the ICMJE recommendations, but can have a marked influence on the results of research, is providing confirmation that the research equipment is accurate, preferably through testing it in accordance with established scientific validation standards. Without such confirmation, there is little to assure that the equipment can measure what it purports to measure, nor whether its use may critically undermine the quality of research outputs. This concept of confirming the quality of all data to increase the confidence in research results is familiar to researchers across disciplines.7, 8, 9

It is not always appreciated that medical equipment may be cleared by regulatory authorities to sell within a country, without ever having been tested for accuracy performance according to scientific validation standards. Instead, manufacturers can undertake in-house accuracy testing, using variable methods and without any requirement for test results to be made publicly available. This lack of full transparency together with potential for industry bias can place doubt over the quality of validation results provided to regulatory authorities. Currently, this situation affects the field of hypertension research,10, 11 where most blood pressure devices have not been independently validated for accuracy according to international scientific standards, nor as expected in clinical practice guidelines.12, 13, 14 Global estimates indicate that less than 20% of blood pressure devices from among thousands of separate models available for purchase have been independently validated.15, 16

As may be anticipated, the untested, non-validated devices are more likely to be inaccurate when compared with established reference standards,17, 18, 19 which in addition to the impact on research quality has obvious implications for appropriate clinical diagnosis and management. Compared with validated devices, those whose accuracy has not been tested also have a greater dispersion of measurement values (higher variance),20 which will influence estimation of sample size for research projects. Higher variance in the measurement of a primary outcome variable means that more research study participants will be needed to answer the research question and demonstrate statistical between-group differences.21 This places extra burden on research resources and also has ethical implications in higher-risk study protocols by needlessly exposing more research participants to otherwise avoidable risk.

Regulatory loopholes that enable widespread availability of blood pressure devices with uncertain quality assurance10 may also apply to other medical equipment used in research, such as blood glucose monitors and pulse oximeters,22, 23, 24 although the breadth of the problem more generally across equipment being used in research is not known. This being the case, the onus of responsibility to determine the worthiness of medical equipment to be used in research falls to the shoulders of individual researchers in the planning and conduct of their research projects. What can researchers do in relation to this?

Researchers can check that all research equipment has been assessed, and passed validation testing, or the performance can be verified (including where participants of the study use personal monitoring equipment to collect research data).17 Ideally, the values derived from the equipment have been compared using an established, standardized protocol with a recognized reference standard, for example, blood glucose measured with a point-of-care device compared with an automated procedure from an accredited laboratory with known accuracy and precision. Researchers can also seek information from relevant professional societies,25 web-based resources,5 other sources of published guidance,26 or ask the equipment distributor to provide published material as proof of accuracy. Where available, they should cite the published validation material within the methods of research manuscripts when referencing the equipment used. It is important to note that validation testing is only relevant to the device under scrutiny and the results cannot be extrapolated to other models or devices made by different manufacturers.

In the hypertension field, international efforts are being undertaken to redress the problem of non-validated equipment used in research, clinical practice and population level interventions.27, 28, 29, 30 This requires ongoing, multisectoral lobbying for regulatory change, as well as widespread education and advocacy for exclusive use of validated equipment. Whether such activities are needed in other research areas is something for the wider research community to be alert for.

Indeed, the scale of the problem being discussed is increasing, and more attention should be paid to it in order to improve the quality of research and to optimize further translation of scientific findings to clinical practice. The clinical implications of inaccurate measurements in research can be far-reaching, ultimately impacting on a patient’s health. Well-planned validating studies should be more widely considered for new devices that are candidates to be used in research protocols. The awareness of the lack or uncertain validation of equipment used for verifying research hypotheses should prompt all investigators to revisit the idea of conducting the study or, at least, to acknowledge this issue as a relevant study limitation. One of the ways that authors submitting research findings for publication can add to the quality of the reporting of their work is to ensure reference to the accuracy validation of their research equipment.

References (30)

  1. Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet. 2009;374(9683):86–89. doi:10.1016/S0140-6736(09)60329-9
  2. National Health and Medical Research Council. NHMRC’s Research Quality Strategy. https://www.nhmrc.gov.au/file/16823/download?token=ha80bBhZ. Accessed November 25, 2021.
  3. Begley CG, Ioannidis JPA. Reproducibility in science: Improving the standard for basic and preclinical research. Circ Res. 2015;116(1):116–126. doi:10.1161/CIRCRESAHA.114.303819
  4. Green S, Mcdonald S. Cochrane Collaboration: More than systematic reviews? Intern Med J. 2005;35(1):3–4. doi:10.1111/j.1445-5994.2004.00747.x
  5. Simera I, Moher D, Hirst A, Hoey J, Schulz KF, Altman DG. Transparent and accurate reporting increases reliability, utility, and impact of your research: Reporting guidelines and the EQUATOR Network. BMC Med. 2010;8:24. doi:10.1186/1741-7015-8-24
  6. International Committee of Medical Journal Editors. Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals – updated December 2018. http://www.ICMJE.org. Accessed August 17, 2019.
  7. Ehrenstein V, Petersen I, Smeeth L, et al. Helping everyone do better: A call for validation studies of routinely recorded health data. Clin Epidemiol. 2016;8:49–51. doi:10.2147/clep.S104448
  8. Lash TL, Olshan AF. EPIDEMIOLOGY announces the “Validation Study” submission category. Epidemiology. 2016;27(5):613–614. doi:10.1097/ede.0000000000000532
  9. Coecke S, Bernasconi C, Bowe G, et al. Practical aspects of designing and conducting validation studies involving multi-study trials. Adv Exp Med Biol. 2016;856:133–163. doi:10.1007/978-3-319-33826-2_5
  10. Alpert BS. Can ‘FDA-cleared’ blood pressure devices be trusted? A call to action. Blood Press Monit. 2017;22(4):179–181. doi:10.1097/mbp.0000000000000279
  11. Sharman JE, Padwal R, Campbell NRC. Global marketing and sale of accurate cuff blood pressure measurement devices. Circulation. 2020;142(4):321–323. doi:10.1161/circulationaha.120.046205
  12. Campbell NR, Gelfer M, Stergiou GS, et al. A call to regulate manufacture and marketing of blood pressure devices and cuffs: A position statement from the World Hypertension League, International Society of Hypertension and supporting hypertension organizations. J Clin Hypertens (Greenwich). 2016;18(5):378–380. doi:10.1111/jch.12782
  13. Muntner P, Einhorn PT, Cushman WC, et al. Blood pressure assessment in adults in clinical practice and clinic-based research: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019;73(3):317–335. doi:10.1016/j.jacc.2018.10.069
  14. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College Of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71(19):e127–e248. doi:10.1016/j.jacc.2017.11.006
  15. Medaval. Blood pressure monitors. https://medaval.ie/blood-pressure-monitors. Accessed October 26, 2021.
  16. Picone DS, Deshpande RA, Schultz MG, et al. Nonvalidated home blood pressure devices dominate the online marketplace in Australia: Major implications for cardiovascular risk management. Hypertension. 2020;75(6):1593–1599. doi:10.1161/HYPERTENSIONAHA.120.14719
  17. Jung MH, Kim GH, Kim JH, et al. Reliability of home blood pressure monitoring: In the context of validation and accuracy. Blood Press Monit. 2015;20(4):215–220. doi:10.1097/mbp.0000000000000121
  18. Akpolat T, Dilek M, Aydogdu T, et al. Home sphygmomanometers: Validation versus accuracy. Blood Press Monit. 2009;14(1):26–31. doi:10.1097/MBP.0b013e3283262f31
  19. Dilek M, Adibelli Z, Aydogdu T, Koksal AR, Cakar B, Akpolat T. Self-measurement of blood pressure at home: Is it reliable? Blood Press. 2008;17(1):34–41. doi:10.1080/08037050701758018
  20. Ringrose JS, Polley G, McLean D, Thompson A, Morales F, Padwal R. An assessment of the accuracy of home blood pressure monitors when used in device owners. Am J Hypertens. 2017;30(7):683–689. doi:10.1093/ajh/hpx041
  21. Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trials to assess equivalence: The importance of rigorous methods. BMJ. 1996;313(7048):36–39. doi:10.1136/bmj.313.7048.36
  22. Medaval. Pulse oximeters. https://medaval.ie/mv-pulse-oximeters. Accessed November 2, 2021.
  23. Medaval. Blood glucose meters. https://medaval.ie/mv-blood-glucose-meters. Accessed November 2, 2021.
  24. Ward JR, Clarkson PJ. An analysis of medical device-related errors: Prevalence and possible solutions. J Med Eng Technol. 2004;28(1):2–21. doi:10.1080/0309190031000123747
  25. Stergiou GS, Alpert B, Mieke S, et al. A universal standard for the validation of blood pressure measuring devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) collaboration statement. Hypertension. 2018;71(3):368–374. doi:10.1161/hypertensionaha.117.10237
  26. Picone DS, Padwal R, Campbell NRC, et al. How to check whether a blood pressure monitor has been properly validated for accuracy. J Clin Hypertens (Greenwich). 2020;22(12):2167–2174. doi:10.1111/jch.14065
  27. Olsen MH, Angell SY, Asma S, et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: The Lancet Commission on Hypertension. Lancet. 2016;388(10060):2665–2712. doi:10.1016/s0140-6736(16)31134-5
  28. Sharman JE, O’Brien E, Alpert B, et al. Declaración de posición del Grupo de la Comisión Lancet de Hipertensión con respecto a la mejora mundial de las normas de exactitud para los dispositivos de medición de la presión arterial. Pan American Journal of Public Health. 2020;44(e21). https://iris.paho.org/bitstream/handle/10665.2/51862/v44e212020.pdf?sequence=1&isAllowed=y. Accessed November 25, 2021.
  29. Sharman JE, O’Brien E, Alpert B, et al. Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure. J Hypertens. 2020;38(1):21–29. doi:10.1097/hjh.0000000000002246
  30. Lombardi C, Sharman JE, Padwal R, et al. Weak and fragmented regulatory frameworks on the accuracy of blood pressure-measuring devices pose a major impediment for the implementation of HEARTS in the Americas. J Clin Hypertens (Greenwich). 2020;22(12):2184–2191. doi:10.1111/jch.14058